INVESTOR OVERVIEW

Corporate Profile

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>

Recent NewsMore >>
04/02/19
Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference
03/28/19
Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
03/08/19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
RYTM (Common Stock) $25.96 Stock is Up 0.27 (0.00%)04/23/19 4:00 p.m. ET
Stock chart for: RYTM.O.  Currently trading at $25.96 with a 52 week high of $37.23 and a 52 week low of $22.10.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming EventsMore >>
There are currently no events scheduled.